tradingkey.logo
tradingkey.logo
検索

Transmedics Group Inc

TMDX
ウォッチリストに追加
67.850USD
+1.430+2.15%
終値 07/01, 16:00ET15分遅れの株価
2.34B時価総額
13.44直近12ヶ月PER

詳細情報 Transmedics Group Inc 企業名

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Transmedics Group Incの企業情報

企業コードTMDX
会社名Transmedics Group Inc
上場日May 02, 2019
最高経営責任者「CEO」Hassanein (Waleed H)
従業員数728
証券種類Ordinary Share
決算期末May 02
本社所在地200 Minuteman Road
都市ANDOVER
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号01810
電話番号19785520900
ウェブサイトhttps://www.transmedics.com/
企業コードTMDX
上場日May 02, 2019
最高経営責任者「CEO」Hassanein (Waleed H)

Transmedics Group Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
16.64K
+58.05%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
15.11K
+19.34%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
6.98K
+41.86%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
5.79K
+50.48%
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
3.00K
+88.95%
Dr. Tamer I. Khayal, M.D.
Dr. Tamer I. Khayal, M.D.
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Edward M. Basile
Mr. Edward M. Basile
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
16.64K
+58.05%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
15.11K
+19.34%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
6.98K
+41.86%

よくある質問

Transmedics Group Incの上位5名の株主は誰ですか?

Transmedics Group Incの上位5名の株主は以下のとおりです。Dr. Waleed H. Hassanein, M.D.

Transmedics Group Inc(TMDX)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Transmedics Group Incの株式を保有している機関は865社あり、保有株式の総市場価値は約42.29Mで、全体の122.36%を占めています。2025Q4と比較して、機関の持ち株は-1737478.00増加しています。

Transmedics Group Incの最大の収益源は何ですか?

2026Q1において、OCS Liver net revenue部門がTransmedics Group Incにとって最大の収益を生み出しており、その金額は460.53Mで、全収益の76.58%を占めています。